SIRT2 and juvenile Huntington disease: Moreover, earlier studies (2007 and 2010) have demonstrated a positive effect of SIRT2 (genetic or pharmacological) inhibition in Huntington’s disease (HD) and Wallerian degeneration [60, 61].